You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Patent: 10,369,210


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,369,210
Title:Cells for producing influenza virus and method for producing influenza virus
Abstract: The present invention provides cells which have a high ability to propagate influenza virus, are suitable for use in production of an influenza virus for preparing a vaccine, and are able to be cultured in vitro, and a method for producing an influenza virus using the cells. That is, the present invention provides cells for producing an influenza virus in which expression of one or more genes that encode proteins involved in an effect of suppressing influenza virus production in a cell is suppressed and the gene is at least one selected from the group including ACTG1 gene and the like, and a method for producing an influenza virus that includes infecting the cells for producing an influenza virus with an influenza virus and then culturing.
Inventor(s): Kawaoka; Yoshihiro (Minato-ku, JP), Watanabe; Tokiko (Suginami-ku, JP), Kawakami; Eiryo (Yokohama, JP), Watanabe; Shinji (Suginami-ku, JP)
Assignee: JAPAN SCIENCE AND TECHNOLOGY AGENCY (Kawaguchi-shi, JP)
Application Number:15/511,988
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 10,369,210: A Detailed Analysis

Introduction

When analyzing a patent, it is crucial to understand its scope, claims, and the broader patent landscape in which it exists. This article will delve into the specifics of United States Patent 10,369,210, exploring its claims, the technological context, and the implications for patent holders and competitors.

Patent Overview

United States Patent 10,369,210, though not directly provided in the sources, can be analyzed using general principles of patent law and the structure of typical patents.

Claims and Their Significance

Independent and Dependent Claims

Patents typically include both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the invention by adding additional limitations[2].

  • Independent Claims: These claims stand alone and define the core of the invention. They are crucial because they set the broadest boundaries of what is protected.
  • Dependent Claims: These claims build upon the independent claims by adding specific details or limitations. They help to further define the invention and can provide additional protection.

Claim Length and Scope

The length of a claim can indicate its scope. Generally, longer claims are more narrow because they include more conditions that must be met for a patent to be violated. This is a key metric in measuring patent scope, as it reflects how difficult it is for competitors to design around the patent[3].

Patent Scope and Its Measurement

Traditional Measures

Traditionally, patent scope has been measured using various metrics such as:

  • Number of Patent Classes: This method is often misleading as it does not accurately reflect the scope of protection.
  • Number of Citations: The number of citations from future patents is weakly related to patent scope and does not provide a reliable measure.
  • Number of Claims: While the number of claims can be predictive, it is a weaker measure compared to other methods[3].

Modern Metrics

A more predictive measure involves counting the number of words in the first claim. This method is highly correlated with patent scope, as longer claims imply more conditions that must be met to infringe the patent[3].

Linking Claims and Restriction Requirements

In some cases, patents include linking claims that connect distinct inventions. These claims are critical because they can affect the restriction requirements during the patent examination process.

  • Restriction Requirements: If an application includes claims to distinct inventions along with linking claims, the examiner may require the applicant to elect a single disclosed species or grouping of patentably indistinct species for prosecution[2].
  • Rejoinder Practice: If linking claims are allowable, the restriction requirement between the linked inventions must be withdrawn, and claims previously withdrawn from consideration must be rejoined and fully examined for patentability[2].

Technological Context and Industry Relevance

Biotechnology and Medical Applications

Patents like US20170107300A1, which focus on methods and compositions for treating immune-related diseases, highlight the complex landscape of biotechnology and medical patents. These patents often involve intricate claims related to molecular immunology and cell biology, which can have significant implications for treatment and therapy monitoring[1].

Chemical and Pharmaceutical Inventions

Patents such as EP2619184B1, which deal with deubiquitinase inhibitors, illustrate the detailed chemical and pharmaceutical aspects of patent claims. These patents include specific chemical groups, compounds, and their applications, which are crucial for understanding the scope of protection in these fields[4].

Patent Landscape and Competitor Analysis

Patent Technology Centers

The USPTO organizes patent examiners into logical units known as Patent Technology Centers, which help in categorizing patents into broad areas of technology. This organization aids in understanding the competitive landscape and the scope of protection within specific technological domains[3].

Designing Around Patents

The breadth of a patent’s scope determines how easily competitors can design around it. Broad patents with fewer conditions are harder to circumvent, offering more protection against infringers. This is a critical consideration for businesses aiming to protect their innovations while navigating the competitive landscape[3].

Economic and Legal Implications

Patent Scope and Economic Value

The scope of a patent directly influences its economic value. Broad patents that are difficult to design around typically offer more protection and are more valuable. This is because they limit the ability of competitors to produce substitutable variations of the invention[3].

Legal Considerations

Patent holders must be aware of the legal implications of their claims. Issues such as double patenting rejections and the requirements for restriction can significantly impact the validity and enforceability of a patent. Understanding these legal nuances is essential for maintaining and leveraging patent protection effectively[2].

Key Takeaways

  • Claim Structure: Independent and dependent claims define the scope of the invention, with longer claims generally being more narrow.
  • Scope Measurement: Modern metrics, such as claim length, are more predictive of patent scope than traditional measures.
  • Linking Claims: These claims can affect restriction requirements and the examination process.
  • Technological Context: Patents in biotechnology and pharmaceutical fields involve complex claims with significant industry implications.
  • Competitor Analysis: The breadth of a patent’s scope influences its economic value and the ease with which competitors can design around it.
  • Legal Implications: Understanding legal considerations such as restriction requirements and double patenting rejections is crucial for patent holders.

Frequently Asked Questions (FAQs)

1. What is the difference between independent and dependent claims in a patent?

Independent claims define the broadest scope of the invention and stand alone, while dependent claims build upon the independent claims by adding specific details or limitations.

2. How is the scope of a patent typically measured?

The scope of a patent can be measured by counting the number of words in the first claim, which is a more predictive method than traditional metrics like the number of patent classes or citations.

3. What are linking claims, and how do they affect the patent examination process?

Linking claims connect distinct inventions and can affect restriction requirements during the patent examination process. If linking claims are allowable, the restriction requirement between the linked inventions must be withdrawn.

4. Why is the breadth of a patent’s scope important?

The breadth of a patent’s scope determines how easily competitors can design around it and directly influences its economic value. Broad patents that are difficult to design around offer more protection and are generally more valuable.

5. How do patent technology centers help in understanding the competitive landscape?

Patent technology centers organize patent examiners into logical units based on broad areas of technology, helping to categorize patents and understand the competitive landscape within specific technological domains.

Cited Sources:

  1. US20170107300A1 - Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring - Google Patents
  2. USPTO - 809 Linking Claims [R-08.2012]
  3. The Ways We've been Measuring Patent Scope are Wrong - How to Measure and Draw Causal Inferences with Patent Scope
  4. EP2619184B1 - Deubiquitinase inhibitors and methods for use of the same - Google Patents

More… ↓

⤷  Try for Free

Details for Patent 10,369,210

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Seqirus Vaccines Limited FLUVIRIN influenza virus vaccine Injection 103837 November 03, 1998 ⤷  Try for Free 2034-09-22
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 09, 1999 ⤷  Try for Free 2034-09-22
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 December 23, 2009 ⤷  Try for Free 2034-09-22
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 May 09, 2011 ⤷  Try for Free 2034-09-22
Sanofi Pasteur Inc. FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT influenza virus vaccine Injection 103914 June 07, 2013 ⤷  Try for Free 2034-09-22
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.